Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Unknown × Acupuncture Points × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1 Patient Compliance 1

Interventions

Cisplatin 240 Carboplatin 166 Oxaliplatin 160 Docetaxel 156 Capecitabine 156 apatinib 149 Paclitaxel 145 Gemcitabine 136 Radiotherapy 131 Bevacizumab 129 camrelizumab 125 Fluorouracil 125 Cyclophosphamide 114 Irinotecan 107 Etoposide 91 Drug Therapy 90 sintilimab 88 S 1 (combination) 74 Leucovorin 72 anlotinib 71 Doxorubicin 70 pembrolizumab 68 tislelizumab 66 toripalimab 64 Pemetrexed 64 Dexamethasone 61 Rituximab 60 Neoadjuvant Therapy 58 Cetuximab 58 Trastuzumab 57

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04749381 2021-02-11

RCT

Peking University Cancer Hospital & Institute

Phase 2 Unknown

Gastrointestinal

Patient Compliance, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡